Tags

Type your tag names separated by a space and hit enter

Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
MMWR Recomm Rep. 1996 Jul 12; 45(RR-11):1-36.MR

Abstract

These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of live, attenuated varicella virus vaccine--VARIVAX--manufactured by Merck and Company, Inc. and licensed in March 1995 for use in healthy persons > or = 12 months of age. In addition to presenting information regarding vaccine, this statement updates previous recommendations concerning the use of varicella zoster immune globulin (VZIG) as prophylaxis against varicella (MMWR 1984; 33:84-90, 95-100).

Pub Type(s)

Guideline
Journal Article
Practice Guideline

Language

eng

PubMed ID

8668119

Citation

"Prevention of Varicella: Recommendations of the Advisory Committee On Immunization Practices (ACIP). Centers for Disease Control and Prevention." MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports, vol. 45, no. RR-11, 1996, pp. 1-36.
Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep. 1996;45(RR-11):1-36.
(1996). Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports, 45(RR-11), 1-36.
Prevention of Varicella: Recommendations of the Advisory Committee On Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep. 1996 Jul 12;45(RR-11):1-36. PubMed PMID: 8668119.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. PY - 1996/7/12/pubmed PY - 1996/7/12/medline PY - 1996/7/12/entrez SP - 1 EP - 36 JF - MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports JO - MMWR Recomm Rep VL - 45 IS - RR-11 N2 - These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of live, attenuated varicella virus vaccine--VARIVAX--manufactured by Merck and Company, Inc. and licensed in March 1995 for use in healthy persons > or = 12 months of age. In addition to presenting information regarding vaccine, this statement updates previous recommendations concerning the use of varicella zoster immune globulin (VZIG) as prophylaxis against varicella (MMWR 1984; 33:84-90, 95-100). SN - 1057-5987 UR - https://www.unboundmedicine.com/medline/citation/8668119/Prevention_of_varicella:_Recommendations_of_the_Advisory_Committee_on_Immunization_Practices__ACIP___Centers_for_Disease_Control_and_Prevention_ L2 - http://www.cdc.gov/mmwr/preview/mmwrhtml/00042990.htm DB - PRIME DP - Unbound Medicine ER -